Cambridge Healthtech Institute

Exclusive interviews with Drs. John March, Cornell University; Karen J.L. Burg, Clemson University; and Jonathan Garlick, Tufts University, Presenters at CHI’s Engineering Functional 3-D Tissue Models Conference.

CHI's event takes place on October 28-30, 2013 in Cambridge, MA. We are accepting scientific posters from industry & academic researchers on improving the screening success of drugs using 3-D models & phenotypic screening.

The industry’s preeminent event on novel drug targets unites 700+ scientists and technologists for key discussions and connections. The event includes 40+ exhibitors, peer posters and keynote presentations by Stuart Schreiber and Paul Feldman.

Jack Ragheb, Ph.D., Principal Investigator, Therapeutic Proteins, FDA/CDER to moderate a roundtable discussion at CHI’s Immunogenicity Summit 2013 this coming November at the Hyatt Regency on Capitol Hill in Washington, DC.

Dr. Lathey sits down with conference producer Samantha Lewis to discuss the biggest challenges to managing bioassay variability, tools and strategies that researchers are using to combat it, and how procedural variation can have unwanted effects.

Complimentary case study download by Deborah Finco, Ph.D., Senior Principal Scientist, Drug Safety R&D, Pfizer, Inc.

Drug R&D Scientists Gather to Discuss Complex Cellular Models Predictive of Human Response to Improve Early Decision Making

Proven assay development and target identification methods to be presented by GSK, Broad, NIH, University of Pittsburg, iRND3, and more this October in Cambridge, MA

Technologies and Strategies for Safe and Efficacious Products in the Clinic

Led by global industry pioneers, Clinical Genomics & Informatics Europe will provide research teams with technologies and strategies for Exome Sequencing, High-Scale Computing, RNA Sequencing, Genome Informatics, Epigenetics and Digital Detection.